Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Chemico-Biological Interactions
|
March 12, 2004
Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases
M Jane Cox Rosemond, Lisa St John-Williams, Toshiro Yamaguchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 19, 2008
An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction
Melinda J Reese, Robert M Wurm, Keith T Muir, et al.
Kidney International Reports
|
May 14, 2019
Metabolomic Patterns in Adolescents With Mild to Moderate CKD
Ellen R Brooks, David C Lin, Craig B Langman, et al.
The Journal of Infectious Diseases
|
June 6, 2020
Metabolomic Signature as a Predictor of Liver Disease Events in Patients With HIV/HCV Coinfection
Susanna Naggie, Sam Lusk, J Will Thompson, et al.
Journal of Proteomics & Bioinformatics
|
May 24, 2016
Optimizing Urine Processing Protocols for Protein and Metabolite Detection
Nazema Y Siddiqui, Laura G DuBois, Lisa St John-Williams, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 6, 2008
An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
Joseph W Polli, Katie L Olson, John P Chism, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
July 2, 2025
Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infection
Tzu-Hao Lee, Kara Wegermann, Rachel Safeek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 25, 2008
The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions
Joseph W Polli, Joan E Humphreys, Kelly A Harmon, et al.
Molecular & Cellular Proteomics : MCP
|
December 30, 2015
Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment
Alistair Harrison, Laura G Dubois, Lisa St John-Williams, et al.
Scientific Reports
|
September 10, 2016
Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI)
Christine Tara Peterson, Joseph Lucas, Lisa St John-Williams, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Chemico-Biological Interactions
|
March 12, 2004
Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases
M Jane Cox Rosemond, Lisa St John-Williams, Toshiro Yamaguchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 19, 2008
An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction
Melinda J Reese, Robert M Wurm, Keith T Muir, et al.
Kidney International Reports
|
May 14, 2019
Metabolomic Patterns in Adolescents With Mild to Moderate CKD
Ellen R Brooks, David C Lin, Craig B Langman, et al.
The Journal of Infectious Diseases
|
June 6, 2020
Metabolomic Signature as a Predictor of Liver Disease Events in Patients With HIV/HCV Coinfection
Susanna Naggie, Sam Lusk, J Will Thompson, et al.
Journal of Proteomics & Bioinformatics
|
May 24, 2016
Optimizing Urine Processing Protocols for Protein and Metabolite Detection
Nazema Y Siddiqui, Laura G DuBois, Lisa St John-Williams, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 6, 2008
An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
Joseph W Polli, Katie L Olson, John P Chism, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
July 2, 2025
Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infection
Tzu-Hao Lee, Kara Wegermann, Rachel Safeek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 25, 2008
The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions
Joseph W Polli, Joan E Humphreys, Kelly A Harmon, et al.
Molecular & Cellular Proteomics : MCP
|
December 30, 2015
Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment
Alistair Harrison, Laura G Dubois, Lisa St John-Williams, et al.
Scientific Reports
|
September 10, 2016
Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI)
Christine Tara Peterson, Joseph Lucas, Lisa St John-Williams, et al.
Page
of 3